| Authors: |
Sohrabi A; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA; Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA., Lefebvre AEYT; Department of Biomedical Engineering, University of California at Irvine, Irvine, CA 92697, USA., Harrison MJ; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA., Condro MC; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Sanazzaro TM; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA., Safarians G; Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA., Solomon I; Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA., Bastola S; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Kordbacheh S; Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA., Toh N; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA., Kornblum HI; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Digman MA; Department of Biomedical Engineering, University of California at Irvine, Irvine, CA 92697, USA., Seidlits SK; Department of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA; Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: seidlits@utexas.edu. |
